London Tech Week day two: Talent alone won’t be enough
The UK’s universities remain some of its strongest assets, but talent alone does not determine startup success, writes Russ Shaw from day two of London Tech Week
Day two of London Tech Week shifted attention from AI infrastructure and sovereignty to a more fundamental challenge: how the UK turns scientific research into companies that scale.
The focus across the stages in Olympia was how we can move discoveries out of universities and into the market at pace, and how to ensure those companies remain and grow domestically.
The data suggests momentum is building. The UK’s university spinout ecosystem has almost tripled in value since 2020, now estimated at £49bn, and the billion-dollar sale of Oxford Ionics has become one of the clearest signals that university-originated quantum companies can attract global strategic interest.
The UK also performs strongly by European standards. Five of the continent’s top 10 universities for spinout value creation are based in Britain, ahead of larger economies such as Germany and France. The pattern is no longer confined to early-stage innovation; it is extending into later funding rounds and acquisition activity, signalling a more mature ecosystem than in previous cycles.
What’s more, the spinout ecosystem is also growing in its geographic footprint.
While London, Oxford and Cambridge continue to anchor much of the activity, the innovation map is widening. Bristol has established itself among Europe’s leading universities for value creation, supported by more than £3bn in venture funding over the past decade. Across the North, the arc linking Manchester, Sheffield, Liverpool and Leeds is becoming a denser industrial and academic corridor, while Dundee and Edinburgh continue to build strength in life sciences and data-driven engineering.
This dispersion is increasingly seen as a structural advantage rather than a secondary effect. A broader base of innovation reduces concentration risk and strengthens the UK’s ability to develop technologies across multiple regions and disciplines.
Despite these gains, the transition from research to scale remains uneven. Many spinouts still face a long journey between laboratory discovery and market entry, often taking 12 to 18 months to move from concept to commercial readiness. Founders frequently split time between academic roles and company-building, slowing execution at precisely the moment speed matters most.
Access to experienced operators remains another constraint. Many early teams lack exposure to founders who have already built and scaled companies, particularly in supply chain development, financial discipline and international expansion.
Policy responses are beginning to address parts of this challenge. The secretary of state for business and trade today announced measures, including visa application fee refunds for the tech sector and a concierge-style support service aimed at reducing friction for early-stage founders. The intent is to help spinouts assemble complete teams more quickly and remove administrative barriers during critical early phases.
The UK’s research base remains one of its strongest assets, but talent alone does not determine scale outcomes. Strong companies require a combination of scientific depth, commercial experience and access to networks that extend beyond academia.
There are also signs of improvement in spinout structure. University equity stakes have fallen to an average of 16 per cent, their lowest level in a decade, bringing the UK closer to international levels and improving alignment between founders and investors.
However, the larger constraint remains further up the funding chain. While early-stage capital is relatively abundant, growth-stage investment is still limited. As companies mature, many are forced to look to the US for the capital required to scale, creating a structural break in the domestic ecosystem.
That gap is being actively discussed across London Tech Week’s main programme and its wider fringe events. Level39 hosted investor-founder formats like “Rev Pitch”, where venture capital firms are put on the spot to compete for startup attention.
If the UK can connect its research strength with deeper pools of growth capital, experienced operators and sustained policy support, it’s well positioned not only to generate world-leading science, but to retain and scale the companies that emerge from it.